RxSight, Inc. Long-Term Debt, Maturity, Year Five
RxSight, Inc. (RXST) had Long-Term Debt, Maturity, Year Five of $5.22 million as of 2023-06-30, per its 10-Q filed 2023-08-07.
Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Four and Five
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive · last filed 2023-08-07
- 2023-06-30: Long-Term Debt, Maturity, Year Five $5.22M.
- 2022-09-30: Long-Term Debt, Maturity, Year Five $1.82M.
- 2022-06-30: Long-Term Debt, Maturity, Year Five $1.82M.
| Period end | Long-Term Debt, Maturity, Year Five |
|---|---|
| 2023-06-30 | $5.22M 10-Q · filed 2023-08-07 |
| 2022-09-30 | $1.82M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $1.82M 10-Q · filed 2022-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |